Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Rhythm receives Michael J. Fox Foundation grant to advance RM-131

Sep. 16, 2013

ALS Therapy Development Institute and Anida Pharma form partnership

Sep. 13, 2013

First patient treated in Neuralstem's phase II trial in ALS

Sep. 13, 2013

Amicus Therapeutics collaborates with Biogen Idec for Parkinson's disease drugs

Sep. 13, 2013

Novel M4 receptor modulators presented by The Vanderbilt University

Sep. 13, 2013

Alcobra reports preclinical data for MG-01CI in mouse model of fragile X syndrome

Sep. 12, 2013

Lundbeck reveals novel NK-3 receptor antagonists

Sep. 12, 2013

Noscira discloses novel GSK-3 inhibitors

Sep. 12, 2013

Biogen Idec and Isis Pharmaceuticals form collaboration for neurological disorders

Sep. 12, 2013

Neurocrine discloses results from phase IIb trial of NBI-98854 for treatment of tardive dyskinesia

Sep. 10, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...